|
Results, summary of the judgements made by the 17 evaluators of the quality for each of the outcomes presented in the 12 examples in the pilot study. |
||||||
| Outcome |
High |
Moderate |
Low |
Very low |
Consensus |
Comments |
|
|
||||||
| Depression severity |
6/17 |
10/17 |
- |
- |
Moderate |
|
| Transient side effects |
7/17 |
10/17 |
- |
- |
High |
Changed to little uncertainty |
| Poisoning fatalities |
- |
4/17 |
7/17 |
6/17 |
Moderate |
Upgraded for very strong association |
| Stroke |
15/17 |
2/17 |
- |
- |
High |
|
| Extracranial hemorrage |
16/16 |
- |
- |
- |
High |
|
| All cause mortality |
12/17 |
5/17 |
- |
- |
- |
Agreed to remove this outcome |
| Pain at rest |
16/17 |
1/17 |
- |
- |
High |
|
| Pain ay motion |
15/17 |
2/17 |
- |
- |
Moderate |
Uncertainty about directness of outcome measure |
| Mobility |
3/17 |
14/17 |
- |
- |
Moderate |
|
| Quality of life |
1/17 |
11/17 |
5/17 |
- |
Moderate |
|
| Dropout due to side effects |
14/17 |
3/17 |
- |
- |
High |
|
| Serious gi complications |
- |
3/17 |
8/17 |
6/17 |
- |
Need more information before consensus |
| All cause mortality |
2/17 |
15/17 |
- |
- |
Moderate |
|
| Non-fatal stroke |
17/17 |
- |
- |
- |
High |
|
| Non-fatal MI |
17/17 |
- |
- |
- |
High |
|
| Death |
13/17 |
4/17 |
- |
- |
High |
|
| Non-fatal MI |
11/16 |
5/16 |
- |
- |
High |
|
| All cause death |
12/17 |
5/17 |
- |
- |
Moderate |
If reporting bias, otherwise high |
| Major bleeding |
15/17 |
2/17 |
- |
- |
High |
|
| Recurrent thromboembolism |
6/17 |
11/17 |
- |
- |
High |
|
| Clinical cure |
- |
13/17 |
4/17 |
- |
Moderate |
|
| Dropout due to side effects |
- |
10/17 |
7/17 |
- |
Moderate |
|
| Relapse |
2/17 |
11/17 |
4/17 |
- |
Moderate |
|
| Tuberculosis |
2/17 |
10/17 |
5/17 |
- |
Moderate |
|
| TB death |
8/17 |
8/17 |
1/17 |
- |
High |
|
| TB meningitis |
1/17 |
4/17 |
12/17 |
- |
Moderate |
Strong association |
| Serious adverse events |
1/12 |
- |
- |
11/12 |
- |
No data, outcome removed |
| Condition unchanged |
5/17 |
19/17 |
2/17 |
- |
- |
No consensus regarding sparse data |
| Poor outcome- surgeon rated |
9/17 |
8/17 |
- |
- |
- |
Need bias information before consensus |
| 2nd procedure needed |
9/17 |
8/17 |
- |
- |
Moderate |
|
| No success – objective rater |
5/17 |
10/17 |
2/17 |
- |
- |
No consensus regarding sparse data |
| Risks & side effects |
1/15 |
2/15 |
2/15 |
10/15 |
- |
No data, outcome removed |
| Dental caries – start |
- |
- |
8/17 |
9/17 |
Very low |
|
| Dental caries – stop |
- |
- |
5/17 |
12/17 |
Very low |
|
| Dental florosis |
- |
1/17 |
3/17 |
13/17 |
Very low |
|
| Bone fracture |
- |
1/17 |
3/17 |
13/17 |
Very low |
|
| Cancer mortality |
- |
1/17 |
2/17 |
14/17 |
Very low |
|
| All injuries |
- |
1/17 |
12/17 |
4/17 |
Very low |
Question changed |
| Correct use early |
8/17 |
5/17 |
4/17 |
- |
High |
Question changed |
| Correct use follow up |
2/17 |
8/17 |
6/17 |
1/17 |
High |
Question changed |
| Possession of seat |
7/17 |
6/17 |
3/17 |
- |
High |
Question changed |
| CHD |
11/13 |
2/13 |
- |
- |
High |
|
| Breast cancer |
11/13 |
2/13 |
- |
- |
High |
|
| Stroke |
11/13 |
2/13 |
- |
- |
High |
|
| Colorectal cancer |
11/13 |
2/13 |
- |
- |
High |
|
| Endometrial cancer |
11/13 |
2/13 |
- |
- |
High |
|
| Hip fracture |
11/13 |
2/13 |
- |
- |
High |
|
Atkins et al. BMC Health Services Research 2005 5:25 doi:10.1186/1472-6963-5-25 |
||||||